Take a look at our previous reports:

Letter from the CEO

Our Sustainability Commitment

Forward, Sustainably

scroll for more

Letter from the CEO – Our Sustainability Commitment – Forward, Sustainably

Since our founding more than two decades ago, we have worked to discover, develop, and commercialize life-changing medicines to add years of life and quality of life for people around the world. Our focus on, and commitment to, patients will always remain at the center of everything we do.

We believe that the quality of life for people living with serious diseases is supported by the health of our planet and the wellbeing of our employees. That is why today, we are extending our commitment to patients by evolving the way we pursue breakthroughs in science and the development of innovative medicines by adopting new strategies and performance metrics to improve the health of our environment, the wellbeing and engagement of our employees, and the ethical and transparent management of our operations.

As a company, we firmly believe that we have to embrace new ways to move “Forward, Sustainably”. In 2022, we decided to build on our key pillars and achievements and further evolve our sustainability approach to better respond to current opportunities and expectations.

Pillars of Sustainability

Patients

People

Trust

Planet

Click icons to explore

Patients

We are engaged:

Our Commitment to Developing Transformational Medicines.

For Patients, With Patients

Read more

People

We are purpose driven:

Our Commitment to Creating a Purposeful Workplace for our People

Read more

Trust

We are transparent:

Our Commitment to Ethical and Sound Business Practices

Read more

Planet

We are conscientious:

Our Commitment to the Health of Our Planet

Read more

Pillars of Sustainability

Pillars of Sustainability (graphic)

Supported by the members of the Executive Committee, we established a Sustainability Steering Committee, comprised of representatives from all departments throughout our organization, and we completed a new materiality analysis. The materiality analysis informs our efforts and allows us to focus our Sustainability ambitions on those areas where we can have the greatest influence and make positive impact: Our Patients, Our People, Planet, and Trust & Transparency.

Our new approach to Sustainability is encapsulated in the principle “Forward, Sustainably”, designed to accelerate progress in our mission to bring more years of life and more quality of life to people around the world. It’s about being ethical and innovative in everything we do, from research and development, to workplace, culture, and leadership. We know that acting as a responsible and sustainable business is key to our success as we continue to focus on the needs of patients who trust and depend on us.

I am proud of all our employees who work hard to embrace the principles behind our Sustainability pillars on a daily basis, and act as ambassadors for our company and values.

Respectfully,

Signature Paul Stoffels (signature)

Dr. Paul Stoffels
CEO and Chairman of the Board of Directors

 

Development
All activities required to bring a new drug to the market. This includes preclinical and clinical development research, chemical and pharmaceutical development and regulatory filings of product candidates